Latest NewsJun 18, 2025HiFiBiO Therapeutics to Present Preclinical Data of Three Leading I&I Programs at the 2025 Annual Meeting of the Federation of Clinical Immunology SocietiesAll Filter By: Year20252024202320222021202020192018201720162015Mar 6, 2023Going Global: Insights on the Advantages of Biotech Globalization Published in Drug Discovery Today from HiFiBiO TherapeuticsJan 6, 2023HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200603Life Science Success Podcast | Podcast | Jan 5, 2023HiFiBiO Therapeutics CEO Liang Schweizer Interviewed by Life Science Success PodcastNov 18, 2022HiFiBiO Therapeutics Announces Clinical Trial Supply Agreement to Evaluate HFB200603 in Combination with Tislelizumab in Patients with DIS® Selected Advanced Solid TumorsSep 5, 2022HiFiBiO Therapeutics to Present Trial in Progress Poster for HFB301001 at 2022 ESMO Congress< 1 … 3 4 5 6 7 … 17 >
